Supernus, Inc. to Participate in the 2026 Jefferies Global Healthcare Conference in London
Key Highlights
- ➤Supernus CEO Jack A. Khattar to join Jefferies healthcare conference fireside chat
- ➤Presentation scheduled November 16, 2026, at 8:30 a.m. EST
- ➤Live webcast and 60-day archived replay available through Supernus investor relations
Expert Statements
Jack A. Khattar, President and CEO of Supernus, Inc.
“Supernus, Inc. is a leading, diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases.”
ROCKVILLE, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Supernus, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A. Khattar, President and CEO of Supernus, Inc., will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in London on Monday, November 16, 2026, at 8:30 a.m. EST (1:30 p.m. GMT).
Investors interested in arranging a meeting with company management during the conference should contact the Jefferies conference coordinator. A live audio webcast of the presentation can be accessed here or by visiting Events & Presentations in the Investor Relations section on the Company's website at www.supernus.com. An archived replay of the webcast will be available for 60 days on the Company's website following the conference.
Get started
Create a free account to read the full story.